Cardiff Park Advisors LLC Buys 2,443 Shares of Cencora, Inc. $COR

Cardiff Park Advisors LLC bought a new stake in Cencora, Inc. (NYSE:COR – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 2,443 shares of the company’s stock, valued at approximately $734,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Deutsche Bank AG bought a new stake in Cencora during the 2nd quarter worth about $286,673,000. SEB Asset Management AB acquired a new position in Cencora during the 1st quarter valued at about $134,139,000. Wedge Capital Management L L P NC lifted its position in Cencora by 31.0% during the 2nd quarter. Wedge Capital Management L L P NC now owns 105,614 shares of the company’s stock valued at $29,887,000 after purchasing an additional 24,968 shares during the period. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Cencora in the 2nd quarter valued at about $841,000. Finally, Peachtree Investment Partners LLC bought a new position in shares of Cencora in the 2nd quarter valued at about $2,204,000. Institutional investors own 97.52% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on COR shares. Wall Street Zen upgraded shares of Cencora from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. Royal Bank Of Canada restated a “sector perform” rating and issued a $330.00 price objective on shares of Cencora in a report on Tuesday, September 8th. Wells Fargo & Company increased their price objective on shares of Cencora from $331.00 to $395.00 and gave the company an “overweight” rating in a report on Tuesday, August 11th. JPMorgan Chase & Co. boosted their target price on shares of Cencora from $390.00 to $413.00 and gave the company an “overweight” rating in a research report on Tuesday, November 10th. Finally, Bank of America boosted their target price on shares of Cencora from $285.00 to $310.00 in a research report on Tuesday, July 21st. Twelve equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Cencora has an average rating of “Moderate Buy” and an average price target of $368.14.

Check Out Our Latest Research Report on COR

Insider Activity at Cencora

In other news, EVP Elizabeth Campbell sold 11,300 shares of the stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $324.12, for a total value of $3,662,556.00. Following the completion of the transaction, the executive vice president owned 19,455 shares of the company’s stock, valued at approximately $6,305,754.60. This represents a 36.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.38% of the company’s stock.

Cencora Trading Up 0.0%

Shares of COR opened at $359.12 on Monday. The company has a debt-to-equity ratio of 3.01, a quick ratio of 0.59 and a current ratio of 0.94. Cencora, Inc. has a 52-week low of $244.82 and a 52-week high of $377.54. The firm has a market cap of $68.53 billion, a price-to-earnings ratio of 20.04, a PEG ratio of 1.86 and a beta of 0.58. The business’s fifty day moving average is $327.12 and its 200-day moving average is $317.20.

Cencora (NYSE:COR – Get Free Report) last announced its quarterly earnings data on Wednesday, November 4th. The company reported $4.66 earnings per share for the quarter, topping the consensus estimate of $4.58 by $0.08. The business had revenue of $88.35 billion during the quarter, compared to the consensus estimate of $87.95 billion. Cencora had a return on equity of 110.72% and a net margin of 1.03%. Cencora’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same period in the prior year, the company earned $3.84 EPS. Equities analysts anticipate that Cencora, Inc. will post 19.58 EPS for the current fiscal year.

Cencora Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 30th. Shareholders of record on Friday, November 13th will be paid a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, November 13th. This is a positive change from Cencora’s previous quarterly dividend of $0.60. This represents a $2.64 annualized dividend and a yield of 0.7%. Cencora’s payout ratio is presently 14.73%.

About Cencora

(Free Report)

Cencora, formerly known as AmerisourceBergen, is a global pharmaceutical services company that connects pharmaceutical manufacturers with healthcare providers. Its core business includes sourcing and distributing medicines and other healthcare products to pharmacies, hospitals, health systems and other care providers. The company also provides services supporting specialty pharmaceuticals, including logistics, consulting and solutions for manufacturers and healthcare organizations. These services help manage the handling and delivery of complex medicines and support access to treatments.

See Also

Want to see what other hedge funds are holding COR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cencora, Inc. (NYSE:COR – Free Report).

Institutional Ownership by Quarter for Cencora (NYSE:COR)

Receive News & Ratings for Cencora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cencora and related companies with MarketBeat.com's FREE daily email newsletter.